| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |